Marksans Pharma News Today

Marksans Pharma Q4 Results Live : Revenue increased by 15.23% YoY & profit decreased by 4.44% YoY

Fourth quarter earnings season is wrapping up with 895 companies reporting results on Thursday. Investors keenly await Apollo Hospitals results, expecting robust growth driven by improved ARPOB and HealthCo operations. Analysts predict up to a 68% YoY increase in net profit, with sales expected to rise by 13%.

Indian shares fell for a fifth straight session on Thursday, pressured by weakness in global peers, while some investors trimmed positions ahead of federal election results. The NSE...

Marksans Pharma received the UK health regulators nod to market its new oral solution for epilepsy patints.

Kenneth Andrade anticipates significant growth in the power market, emphasizing massive investments in energy capex equivalent to Indias GDP over the next 15 years. He discusses the impact on various sectors and the rationale behind his pharma holdings, focusing on profitability potential. Andrade says he is avoiding banks because he chooses to be on the asset side and not on the liability side.

MITs recent investment in Marksans Pharma underscores the small-caps hidden gem status, fuelled by its strong presence in stable OTC markets and strategic growth initiatives, signalling promising prospects for revenue and profit expansion.

Marksans Pharma Q3 FY24 Results Live: Revenue increased by 22.15% YoY & profit increased by 31.27% YoY

Barring two companies – Balrampur Chini Mills and Shree Cement – rest of the stocks have given atleast double-digit returns so far in the current financial year.

Global healthcare-focussed mid-market private equity firm OrbiMed, which counts companies like Advanced Enzymes, Entero Healthcare, Marksans Pharma, Suraksha Clinic, Kapiva, Bharat Serum, and Asian Institute ......

Arcatron Mobility has raised growth capital from OrbiMed, a global healthcare-focused investment firm. The funds will be used to increase R&D, develop new products, and improve branding and marketing. Arcatron offers mobility assist devices under its flagship brand "Frido" and offers products across leading e-commerce platforms, its website, and over 1,000 stores across India.